文献速递关节外科

甲哌卡因与布比卡因脊髓麻醉在全髋和全膝关节置换术中运动功能恢复更具可预测性:一项双盲随机临床试验

More Predictable Return of Motor Function with Mepivacaine Versus Bupivacaine Spinal Anesthetic in Total Hip and Total Knee Arthroplasty: A Double-Blinded, Randomized Clinical Trial.
PubMed 文献 · J Bone Joint Surg Am · 2020-01-01

该单中心双盲随机对照试验纳入154例初次全髋或全膝关节置换患者,比较甲哌卡因与低剂量布比卡因脊髓麻醉后下肢运动功能恢复情况。甲哌卡因组运动功能恢复超过5小时者占1%,低于布比卡因组的11%(p=0.013);甲哌卡因组下肢运动功能恢复平均时间185分钟,比布比卡因组的210分钟快26分钟(p=0.016)。两组安全性结局无显著差异。

要点

  • 甲哌卡因组运动功能恢复超过5小时者占1%,布比卡因组占11%(p=0.013)。
  • 甲哌卡因组下肢运动功能恢复平均185分钟,比布比卡因组210分钟快26分钟(p=0.016)。
  • 两组疼痛评分、物理治疗参与时间、直立性低血压、尿潴留及短暂神经症状无显著差异。

核心结论

  • 在初次全髋和全膝关节置换患者中,甲哌卡因脊髓麻醉较低剂量布比卡因使下肢运动功能恢复更一致,且未伴随脊髓麻醉相关并发症增加。

研究设计与样本

  • 前瞻性、双盲、随机临床试验,在单一学术机构进行,根据手术类型、年龄组、性别和体重指数采用先进计算机分层按1:1随机分组。
  • 试验启动前内部预试验确定需154例患者以达到80%把握度。
  • 术后每15分钟采用Bromage量表评估非手术侧下肢运动功能,达到Bromage 0(髋、膝、踝自主运动)后停止评估。

主要发现

  • 甲哌卡因组运动功能恢复超过5小时者占1%,布比卡因组占11%(p=0.013)。
  • 甲哌卡因组下肢运动功能恢复平均时间185分钟(95%CI 174至196分钟),比低剂量布比卡因组210分钟(95%CI 193至228分钟)快26分钟(p=0.016)。
  • 两组在疼痛评分、物理治疗参与时间、直立性低血压发生率、尿潴留或短暂神经症状方面无显著差异。

关键数值与推荐

  • 运动功能恢复超过5小时:甲哌卡因组1% vs 布比卡因组11%(p=0.013)。
  • 下肢运动功能恢复平均时间:甲哌卡因组185分钟(95%CI 174至196分钟) vs 低剂量布比卡因组210分钟(95%CI 193至228分钟),甲哌卡因组快26分钟(p=0.016)。

临床怎么用

  • 作者认为,在初次全髋和全膝关节置换患者中,甲哌卡因脊髓麻醉较低剂量布比卡因使下肢运动功能恢复更一致,且未伴随脊髓麻醉相关并发症增加,在短停留和门诊手术时代尤其有价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Spinal anesthesia provides several benefits for patients undergoing total hip arthroplasty (THA) and total knee arthroplasty (TKA), but historically comes at the cost of slow and unpredictable return of lower-extremity motor function related to the use of long-acting local anesthetics. In this prospective, double-blinded, randomized clinical trial we sought to determine if an alternative local anesthetic, mepivacaine, would allow more consistent return of motor function compared with low-dose bupivacaine spinal anesthesia during primary THA and TKA. METHODS: This trial was conducted at a single academic institution. Prior to trial initiation an internal pilot study determined that 154 patients were required to achieve 80% power. Patients were randomized in a 1:1 fashion with use of advanced computerized stratification based on procedure, age group, sex, and body mass index. Following the surgical procedure, motor function was assessed every 15 minutes in the nonoperative lower extremity according to the Bromage scale and discontinued once Bromage 0 was achieved (spontaneous movement at hip, knee, and ankle). RESULTS: Return of lower-extremity function was more predictable in patients who received mepivacaine than in those who received low-dose bupivacaine. Among patients who received mepivacaine, 1% achieved motor function return beyond 5 hours compared with 11% of patients who received bupivacaine (p = 0.013). The mean time to return of lower-extremity motor function was 26 minutes quicker in patients who received mepivacaine (185 minutes; 95% confidence interval, 174 to 196 minutes) compared with low-dose bupivacaine (210 minutes; 95% confidence interval, 193 to 228 minutes) (p = 0.016). There were no significant differences in safety outcomes including pain scores, time to participation in physical therapy, incidence of orthostatic hypotension, urinary retention, or transient neurologic symptoms in patients receiving mepivacaine compared with low-dose bupivacaine. CONCLUSIONS: In patients undergoing primary THA and TKA, spinal anesthesia with mepivacaine allowed more consistent return of lower-extremity motor function compared with low-dose bupivacaine, without a concomitant increase in complications potentially associated with spinal anesthetics. This is particularly of value in an era of short-stay and outpatient surgical procedures. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Wyles CC, Pagnano MW, Trousdale RT, et al. More Predictable Return of Motor Function with Mepivacaine Versus Bupivacaine Spinal Anesthetic in Total Hip and Total Knee Arthroplasty: A Double-Blinded, Randomized Clinical Trial. J Bone Joint Surg Am. 2020. PMID: 32960532. doi:10.2106/JBJS.20.00231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。